Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2015 · 10-Q
Revenue$117.00K$117.00K+1.7% vs Q1 2014 Net Income-$1.93M-$1.93MN/M vs Q1 2014 EPS Diluted-$0.05-$0.05N/M vs Q1 2014 Operating Income-$1,930,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Margins · derivedOperating margin-1649.6%+1682.6 pt vs Q1 2014
Net margin-1653.0%+1689.6 pt vs Q1 2014
ended Oct 31, 2014 · filed Dec 11, 2014 · 41 d after period end